Acrux, TruPharma Launch Dapsone 5% Gel in US

Pharmaceutical company Acrux (ASX:ACR) and its partner TruPharma introduced a generic version of the topical prescription medication Dapsone 5% Gel in the US, according to a Wednesday filing with the

MT NewswiresApr 2 20:33 ET

Acrux Gets AU$3 Million Tax Rebate for Fiscal Year 2023

Acrux (ASX:ACR) received a rebate worth AU$2.9 million for the fiscal year ended June 30 as part of the Australian government's research and development tax incentive scheme. The scheme aims to encour

MT NewswiresNov 7, 2023 23:19 ET

US FDA Approves Review of Acrux (ASX:ACR) Nitroglycerin Ointment

The Market HeraldJul 3, 2023 22:59 ET

Acrux Limited (ASX:ACR) Insider Purchases A$91,665.00 in Stock

Acrux Limited (ASX:ACR – Get Rating) insider Donald Brumley bought 1,455,000 shares of the business's stock in a transaction dated Thursday, March 9th. The shares were purchased at an average cost of

Defense WorldMar 13, 2023 05:53 ET

Acrux Limited (ASX:ACR) Insider Buys A$91,665.00 in Stock

Acrux Limited (ASX:ACR – Get Rating) insider Donald Brumley acquired 1,455,000 shares of Acrux stock in a transaction that occurred on Thursday, March 9th. The stock was purchased at an average cost o

Financial News LiveMar 10, 2023 10:29 ET

Acrux (ASX:ACR) Announces Buyout of Future Lenzetto Royalties

The Market HeraldJan 23, 2023 00:16 ET